Injectable and adhesive hydrogels for dealing with wounds
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 6, 2021 Category: Drugs & Pharmacology Authors: Parisa Ghandforoushan Nasim Golafshan Firoz Babu Kadumudi Miguel Castilho Alireza Dolatshahi-Pirouz Gorka Orive Source Type: research

Near-infrared photoimmunotherapy for the treatment of skin disorders
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 3, 2021 Category: Drugs & Pharmacology Authors: Irene Russo Laura Fagotto Anna Colombo Emma Sartor Roberto Luisetto Mauro Alaibac Source Type: research

Statement of Retraction
Volume 21, Issue 12, December 2021, Page 1-2 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 3, 2021 Category: Drugs & Pharmacology Source Type: research

The Role of Anti-IL-1 Treatment in MIS-C Patients
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 26, 2021 Category: Drugs & Pharmacology Authors: Maria Vincenza Mastrolia Edoardo Marrani Ilaria Maccora Ilaria Pagnini Gabriele Simonini Source Type: research

Alternative therapeutic strategy for existing aortic aneurysms using mesenchymal stem cell –derived exosomes
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 26, 2021 Category: Drugs & Pharmacology Authors: Motoshi Kozakai Yuji Narita Aika Yamawaki-Ogata Kazuro L Fujimoto Masato Mutsuga Yoshiyuki Tokuda Akihiko Usui Source Type: research

Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancer
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 22, 2021 Category: Drugs & Pharmacology Authors: Ashley Matusz-Fisher Antoinette R. Tan Source Type: research

A comparative multi-tiered immunogenicity assessment of biosimilar pegylated filgrastim: validation of methods for clinical assessment of INTP5
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 19, 2021 Category: Drugs & Pharmacology Authors: Pallavi Hajela Ronak Patel Prashant Kale Manish Kumar Sridevi Khambhampaty Source Type: research

Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 17, 2021 Category: Drugs & Pharmacology Authors: Fatma G ül Demirkan Kadir Ulu K übra Öztürk Şerife Gül Karadağ Semanur Özdel Hafize Emine S önmez Figen Çakmak Ferhat Demir Bet ül Sözeri Nuray Aktay Ayaz Source Type: research

Moving toward personalized approaches in the management of lupus nephritis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 12, 2021 Category: Drugs & Pharmacology Authors: Savino Sciascia Roberta Fenoglio Dario Roccatello Source Type: research

Distinguishing features of a novel humanized anti-EGFR monoclonal antibody based on cetuximab with superior antitumor efficacy
Volume 21, Issue 11, November 2021, Page 1491-1507 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 11, 2021 Category: Drugs & Pharmacology Authors: Pei-Hua Lin Chi-Ling Tseng Yun-Chih Cheng Chieh-Hsin Ho Shih Chieh Chen Yanling Wang Eugene Liu Hassan Issafras Weidong Jiang Source Type: research

Total pancreatectomy with intraportal islet autotransplantation for pancreatic malignancies: a literature overview
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 8, 2021 Category: Drugs & Pharmacology Authors: Mohamed Ali Chaouch Piera Leon Gianluca Cassese Caroline Aguilhon Salah Khayat Fabrizio Panaro Source Type: research

Is there still a role for talimogene laherparepvec (T-VEC) in advanced melanoma? An indirect efficacy comparison of T-VEC plus ipilimumab combination therapy versus T-VEC alone as salvage therapy in unresectable metastatic melanoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 1, 2021 Category: Drugs & Pharmacology Authors: Mohammad Fazel Neda AlRawashdh Ahmad Alamer Clara Curiel-Lewandrowski Ivo Abraham Source Type: research

Cardiometabolic comorbidity in the selection of treatment in spondyloarthritis: one step closer to truly personalized medicine?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 1, 2021 Category: Drugs & Pharmacology Authors: Rub én Queiro Source Type: research

Conventional type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 27, 2021 Category: Drugs & Pharmacology Authors: Phillip Johnson Nikita Rosendahl Kristen J Radford Source Type: research

Bispecific antibodies for the treatment in inflammatory bowel disease: an avenue worth exploring?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 22, 2021 Category: Drugs & Pharmacology Authors: B énédicte Caron Patrick Netter Silvio Danese Laurent Peyrin-Biroulet Source Type: research

Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 22, 2021 Category: Drugs & Pharmacology Authors: Mina Hosseini Zahra Habibi Narges Hosseini Sina Abdoli Nima Rezaei Source Type: research

Evaluation of canine bone marrow-derived mesenchymal stem cells for experimental full-thickness cutaneous wounds in a diabetic rat model
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 20, 2021 Category: Drugs & Pharmacology Authors: Deepika Bist A. M. Pawde Amarpal Prakash Kinjavdekar Reena Mukherjee K. P. Singh Med Ram Verma Khan Sharun Amit Kumar Pawan K. Dubey Divya Mohan Amit Verma G. Taru Sharma Source Type: research

A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta ® in healthy Chinese male subjects
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 18, 2021 Category: Drugs & Pharmacology Authors: Guangwen Liu Zhongnan Xu Wei Yang Jinling Xue Yanli Wang Zhengzhi Liu Yingzi Cui Xinyao Qu Tianying Chang Shuang Yu Yang Cheng Yannan Zhou Jiahui Chen Qing Ren Wanhua Wang Qiaohuan Deng Zeyu Wang Haimiao Yang Source Type: research

Analytical similarity assessment of MYL-1402O to reference Bevacizumab
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 13, 2021 Category: Drugs & Pharmacology Authors: Parag Goyal Bhavesh Vats Malini Subbarao Chethan Gejjalagere Honnappa Pradeep Kabadi Sheija Rohil Arnab Bera Gaurav R Mehta Harish Pai Laxmi Adhikari Ranitendranath Tagore Shulagna Sharma Roopa Venkatachala Pradip Nair Shankara Annegowda Abhilashi Sahu Sn Source Type: research

Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 12, 2021 Category: Drugs & Pharmacology Authors: Marco Galluzzo Andrea Chiricozzi Elisa Cinotti Giovanna Brunasso Maurizio Congedo Maria Esposito Chiara Franchi Giovanna Malara Alessandra Narcisi Stefano Piaserico Rossana Tiberio Giuseppe Argenziano Gabriella Fabbrocini Aurora Parodi Source Type: research

Development of multi-epitope vaccine constructs for non-small cell lung cancer (NSCLC) against USA human leukocyte antigen background: an immunoinformatic approach toward future vaccine designing
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 29, 2021 Category: Drugs & Pharmacology Authors: Sana Batool Duaa Bin-T-Abid Hina Batool Saher Shahid Mahjabeen Saleem Azmat Ullah Khan Arslan Hamid Malik Siddique Mahmood Naeem Mahmood Ashraf Source Type: research

Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 29, 2021 Category: Drugs & Pharmacology Authors: Sheila A. Doggrell Source Type: research

Medical students ’ knowledge and awareness levels about biologics and biosimilars: the earlier the better?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 27, 2021 Category: Drugs & Pharmacology Authors: Devrim Demir-Dora Zinnet Şevval Aksoyalp Source Type: research

One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 27, 2021 Category: Drugs & Pharmacology Authors: Michele Francesco Chiappetta Anna Viola Mauro Mastronardi Laura Turchini Sonia Carparelli Adele Orlando Giuseppe Biscaglia Agnese Miranda Laura Guida Giuseppe Costantino Franco Scaldaferri Fabrizio Bossa Sara Renna Maria Cappello Angela Alibrandi Ambrogio Source Type: research

Identifying and managing CAR T-cell –mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 16, 2021 Category: Drugs & Pharmacology Authors: Massimo Martino Sebastiano Macheda Umberto Aguglia Luciano Arcudi Giulia Pucci Bruno Martino Maria Altomonte Antonio Maria Rossetti Giuseppa Cusumano Letteria Russo Lucrezia Imbalzano Caterina Stelitano Caterina Alati Jessyca Germano ’ Demetrio Labate V Source Type: research

Rotavirus vaccines: progress and new developments
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 10, 2021 Category: Drugs & Pharmacology Authors: Jordan E. Cates Jacqueline E. Tate Umesh Parashar Source Type: research

Loncastuximab tesirine for treatment of relapsed or refractory diffuse large B cell lymphoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 10, 2021 Category: Drugs & Pharmacology Authors: Krishna Goparaju Paolo F. Caimi Source Type: research

Need for a risk-based control strategy for managing glycosylation profile for biosimilar products
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 1, 2021 Category: Drugs & Pharmacology Authors: Anurag Rathore Himanshu Malani Source Type: research

Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 30, 2021 Category: Drugs & Pharmacology Authors: Carlo Alberto Maronese Enrico Zelin Chiara Moltrasio Giovanni Genovese Angelo Valerio Marzano Source Type: research

A randomized pharmacokinetic/pharmacodynamic study comparing the bioequivalence of potential biosimilar candidate P044 with reference medicine in healthy volunteers
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 25, 2021 Category: Drugs & Pharmacology Authors: Ekaterina Raykova Mohammad Farmahini Farahani Stanislava Ivanova Morteza Azhdarzadeh Source Type: research

Current status of developing tissue engineering vascular technologies
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 24, 2021 Category: Drugs & Pharmacology Authors: Ryuma Iwaki Toshihiro Shoji Yuichi Matsuzaki Anudari Ulziibayar Toshiharu Shinoka Source Type: research

Luspatercept for β-thalassemia: beyond red blood cell transfusions
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 23, 2021 Category: Drugs & Pharmacology Authors: Ali T. Taher Maria Domenica Cappellini Source Type: research

KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 18, 2021 Category: Drugs & Pharmacology Authors: Dahna Coupez Pauline Hulo Yann Touchefeu Marc G Denis Jaafar Bennouna Source Type: research

Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 17, 2021 Category: Drugs & Pharmacology Authors: Marina Talamonti Marco Galluzzo Source Type: research

Anti -TNF α agents in preventing the postoperative recurrence of Crohn’s disease: Do they still play a role in the biological era?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 16, 2021 Category: Drugs & Pharmacology Authors: Caiguang Liu Na Li Shukai Zhan Zhenyi Tian Dongxuan Wu Tong Li Zhirong Zeng Xiaojun Zhuang Source Type: research

The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis
Volume 21, Issue 9, September 2021, Page 1143-1149 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 12, 2021 Category: Drugs & Pharmacology Authors: Jeffrey P Aldinger Taylor Dobyns Kent Lam Joseph K Han Source Type: research

The role of omalizumab in the treatment of chronic rhinosinusitits with nasal polyposis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 12, 2021 Category: Drugs & Pharmacology Authors: Jeffrey P Aldinger Taylor Dobyns Kent Lam Joseph K Han Source Type: research

Experts ’ review: the emerging roles of romiplostim in immune thrombocytopenia (ITP)
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 12, 2021 Category: Drugs & Pharmacology Authors: Frederick Chen Vickie McDonald Adrian Newland Source Type: research

Reduction/elimination of blood eosinophils in severe asthma: should there be a safety consideration?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 10, 2021 Category: Drugs & Pharmacology Authors: Konstantinos Katsoulis Maria Kipourou Stelios Loukides Source Type: research

Biosimilars in chronic inflammatory diseases: facts and remaining questions 5 years after their introduction in Europe
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 9, 2021 Category: Drugs & Pharmacology Authors: Christian Agboton Joseph Salameh Source Type: research

Association between cumulative rATG induction doses and kidney graft outcomes and adverse effects in kidney transplant patients: a systematic review and meta-analysis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 5, 2021 Category: Drugs & Pharmacology Authors: Keyhan Mohammadi Behrouz Khajeh Simin Dashti-Khavidaki Sakineh Shab-bidar Source Type: research

Therapeutic potential of biologics in prurigo nodularis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 4, 2021 Category: Drugs & Pharmacology Authors: Svenja M üller Thomas Bieber Sonja St änder Source Type: research

Classification and coding of platelet-rich plasma derived from New Zealand white rabbits for tissue engineering and regenerative medicine applications
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 28, 2021 Category: Drugs & Pharmacology Authors: Khan Sharun Abhijit M. Pawde K. M. Manjusha Amitha Banu S E. Kalaiselvan Rohit Kumar Prakash Kinjavdekar Amarpal Med Ram Verma Source Type: research

Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 26, 2021 Category: Drugs & Pharmacology Authors: Wenliang Dong Min Chen Suping Niu Bianzhen Wang Lin Xia Jiaxue Wang Tiantian Shen Qian Wang Jie Lv Gang Liu Huaying Fan Zhenwei Xie Fan Xie Youzhong an Qingshan Zheng Huiying Rao Haifeng Song Yi Fang Source Type: research

Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 22, 2021 Category: Drugs & Pharmacology Authors: Gerhard Hamilton Maryana Teufelsbauer Source Type: research

Flow cytometry and receptor occupancy in immune-oncology
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 19, 2021 Category: Drugs & Pharmacology Authors: Alessandra Audia Gregory Bannish Rachel Bunting Chelsea Riveley Source Type: research

Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 19, 2021 Category: Drugs & Pharmacology Authors: E Anitua B de la Sen-Corcuera G Orive RM S ánchez-Ávila P Heredia F Muruzabal J Merayo-Lloves Source Type: research

Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 18, 2021 Category: Drugs & Pharmacology Authors: Arianna Zangrilli Giacomo Caldarola Nicoletta Bernardini Mauro Bavetta Dario Graceffa Claudio Bonifati Franca Cantoresi Sara Faleri Domenico Giordano Marco Mariani Adriana Micheli Gaia Moretta Federico Pirro Gianluca Pagnanelli Vincenzo Panasiti Alessia P Source Type: research

IL-23 inhibition for the treatment of psoriatic arthritis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 15, 2021 Category: Drugs & Pharmacology Authors: Raagav Mohanakrishnan Secia Beier Atul Deodhar Source Type: research

The impact of anti-TNF α agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 8, 2021 Category: Drugs & Pharmacology Authors: Faizan Mazhar Vera Battini Michele Gringeri Marco Pozzi Giulia Mosini Albaraa Mohammed N. Marran Shahzad Akram Robbert P. van Manen Sonia Radice Emilio Clementi Carla Carnovale Source Type: research